Sirios Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Sirios Capital Management's PFE Position: Q3 2023 in Review
Sirios Capital Management sold out of Pfizer (PFE) in Q3 2023, closing a stake of 157,964 shares — an estimated $5.79M sold.
Sirios Capital Management first reported a position in PFE in Q1 2020 and held it in 14 quarters. The position peaked at $52.7M in Q1 2020. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.
- Sirios Capital Management reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
- Sirios Capital Management sold 157,964 Pfizer shares in Q3 2023, an estimated $5.79M.
- Sirios Capital Management first reported a position in Pfizer in Q1 2020 and held it in 14 quarters.
- Sirios Capital Management's Pfizer position peaked at $52.7M in Q1 2020.
- 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.
Based on Sirios Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.